ABBV Q2'26 Earnings: revenue estimate is 16.79B USD

Q2'25

Q3'25

Q4'25

Q1'26

Q2'26

Revenue Reported

15.42 B

15.78 B

16.62 B

15.00 B

—

Revenue Estimate

15.03 B

15.59 B

16.41 B

14.72 B

16.79 B

Revenue Surprise

+2.62%

+1.22%

+1.25%

+1.93%

EPS Reported

2.97

1.86

2.71

2.65

EPS Estimate

2.88

1.77

2.65

2.59

3.60

EPS Surprise

+3.12%

+5.34%

+2.15%

+2.25%

ABBV (AbbVie Inc.) is set to announce its Q2'26 results on July 31, before the market opens. The earnings are expected to be disclosed at 9:30 AM ET (1:30 PM UTC).For Q2'26, revenue estimate is 16.79 billion USD with EPS (earnings per share) anticipated at 3.60 USD. Learn more details at .Revenue & EPS values are provided in USDQ2'25Q3'25Q4'25Q1'26Q2'26Revenue Reported15.42 B15.78 B16.62 B15.00 B—Revenue Estimate15.03 B15.59 B16.41 B14.72 B16.79 BRevenue Surprise+2.62%+1.22%+1.25%+1.93%EPS Reported2.971.862.712.65EPS Estimate2.881.772.652.593.60EPS Surprise+3.12%+5.34%+2.15%+2.25%DisclaimerSelect reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.

ABBV (AbbVie Inc.) is set to announce its Q2'26 results on July 31, before the market opens. The earnings are expected to be disclosed at 9:30 AM ET (1:30 PM UTC).

For Q2'26, revenue estimate is 16.79 billion USD with EPS (earnings per share) anticipated at 3.60 USD. Learn more details at .

Revenue & EPS values are provided in USD

	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26
Revenue Reported	15.42 B	15.78 B	16.62 B	15.00 B	—
Revenue Estimate	15.03 B	15.59 B	16.41 B	14.72 B	16.79 B
Revenue Surprise	+2.62%	+1.22%	+1.25%	+1.93%
EPS Reported	2.97	1.86	2.71	2.65
EPS Estimate	2.88	1.77	2.65	2.59	3.60
EPS Surprise	+3.12%	+5.34%	+2.15%	+2.25%

Disclaimer